Investigators are evaluating a variety of medications for the novel coronavirus disease 2019 (COVID- 19), and the possible treatment landscape is rapidly evolving.
“Are employers really stepping up to take care of their health providers? I think [that] is something that also probably needs to change.”
“Testing is coming, but getting there is a step-by-step process, and you need to work out the logistics.”
The current pandemic could lead to heightened demand for retail pharmacists and pharmacy technicians.
Never before have so many brilliant minds, machines, and groups come together so quickly in an attempt to develop a vaccine.
As the global COVID-19 pandemic and consequent public health crisis continues on, health care providers on the frontlines of this crisis deserve all of the support needed to continue serving their patients.
Pharmacies, just as expected, have showed up in meaningful ways to support their communities.
Perspectives from pharmacy associations in the states hardest hit with the COVID-19 outbreak.
FDA should provide better education about biosimilar drugs on the agency’s web site dedicated to biosimilars, a patient advocacy group said.
FDA approved a new indication for Exparel Bupivacaine Liposome injectable suspension (Exparel, Pacira) for use as a nerve block to produce post-surgical regional analgesia following shoulder surgery in adults.
Over the past few months, several new diabetes treatments have been approved by FDA. Here are the top 3 novel drugs for diabetes.
Effective patient counseling improves patient adherence. Here’s some things you can do to enhance your skills.
Direct oral anticoagulants have expanded treatment options for patients with venous thromboembolisms, but they are not for everyone.
